Skip to main content
Equibles

Wealthspire Advisors, LLC

Position in GALT — Galectin Therapeutics Inc

CIK 1646247 NEW YORK, NY
Back to GALT Full portfolio

Position in GALT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,349,096
+$1,335,308 QoQ
Shares Held
721,788
0.0% QoQ
Ownership
0.716%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 98 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GALT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Wealthspire Advisors, LLC holds $11,785,631 across 19 Biotechnology names. GALT ranks #2 (28.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 7,042 $4,390,968
2 GALT
Galectin Therapeutics Inc
This page 		721,788 $3,349,096
3 OCUL
Ocular Therapeutix, Inc
 162,960 $1,600,267
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,138 $565,278
5 CORT
Corcept Therapeutics Inc
 3,540 $307,803
6 MRNA
Moderna, Inc.
 3,953 $276,828
7 RNXT
RenovoRx, Inc.
 252,525 $247,474
8 MREO
Mereo BioPharma Group plc
 765,000 $243,270

All Filings in GALT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,349,096 721,788
2026-03-31 $2,013,788 721,788
2025-12-31 $2,504,207 601,973
2025-09-30 $2,033,156 479,518
2025-06-30 $1,011,782 479,518
2025-03-31 $486,016 398,374
2024-12-31 $513,902 398,374
2024-09-30 $1,095,528 398,374
2024-06-30 $900,325 398,374
2024-03-31 $952,113 398,374
2023-12-31 $305,210 183,862
2023-09-30 $353,015 183,862
2023-06-30 $264,761 183,862
2023-03-31 $386,110 183,862
2022-09-30 $28,288 17,355
2022-06-30 $22,735 17,355
2022-03-31 $27,941 17,355
2021-12-31 $28,679 13,855
2021-09-30 $53,757 13,855
2021-06-30 $44,336 13,855
2021-03-31 $30,065 13,855
2020-12-31 $31,035 13,855
2020-09-30 $36,992 13,855
2020-06-30 $42,396 13,855
2020-03-31 $27,155 13,855